ArticleFrontiers in pharmacology2026
Mechanistic insights into Strontium-90 superficial radiotherapy in keloids: senescence-associated changes and ECM remodeling across cell-matrix scales.
Article in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The limited efficacy of current keloid therapies necessitates a deeper understanding of treatment mechanisms. This study investigates the therapeutic potential and underlying pharmacological actions of strontium-90 (Sr-90) superficial radiotherapy, evaluating a dual-component antifibrotic working model. Methods: The effects of Sr-90 irradiation were studied in primary keloid fibroblasts and a rabbit ear scar model. We assessed cell proliferation, migration, senescence (SA-β-gal), and DNA damage. Molecular profiling (Western blot, RT-qPCR, enzymatic assays) evaluated the p53-p21-DNA damage response axis and lysyl oxidase (LOX/LOXL2) pathway. Transcriptomic analysis (RNA-seq) with GO/KEGG enrichment was performed. Collagen ultrastructure and crosslinking-related indices were analyzed, alongside tissue remodeling evaluated by multimodal imaging optical coherence tomography and biomechanics (nanoindentation). Functional validation used Pifithrin-α and β-aminopropionitrile (BAPN). Results: Sr-90 irradiation was accompanied by activation of the p53-p21-DDR pathway, increased senescence-associated features, and reduced fibroblast proliferation and migration. Concurrently, it suppressed LOX/LOXL2 expression and activity, accompanied by changes in collagen crosslinking-related indices and improved tissue elasticity. Transcriptomics revealed downregulation of genes in extracellular matrix (ECM) organization, focal adhesion, and PI3K-Akt signaling. These changes were accompanied by reduced collagen deposition, disassembly of the collagen network, decreased fibrotic thickness, and restoration of tissue mechanical properties. P53 pathway inhibition attenuated these effects, whereas LOX inhibition further enhanced the matrix-remodeling response. Animal findings were generally consistent with the Conclusion: Sr-90 irradiation was associated with fibroblast senescence and accompanying p53-p21-DDR activation, together with reduced LOX/LOXL2 expression and activity, which may contribute to attenuation of collagen crosslinking-related matrix stabilization. These parallel cellular and matrix-associated changes may jointly promote scar remodeling by affecting both fibroblast behavior and ECM architecture. These findings provide preliminary mechanistic support for further investigation of Sr-90 superficial radiotherapy and matrix-targeted combination strategies in keloid fibrosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.